Prospectus

Alaunos Therapeutics, Inc. Filed 2020-02-04 Acc 0001193125-20-024354

Documents 1

2020-02-06 8-K Material agreement · Other events
2020-02-06 SC 13G/A Amended Statement of Ownership
2020-02-05 424B5 Prospectus
2020-02-05 8-K Results of operations · Other events
2020-02-04 424B5 Prospectus
2020-01-31 4 EVP, Chief Financial Officer acquired 80,500 shares (grant or award)
2017-05-12 424B5 Prospectus

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading d845656d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…